Direct Oral Anticoagulants (DOACs)

Type: drug

Status: FDA Approved

Developer: Various (e.g., Bayer, Bristol-Myers Squibb, Pfizer)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026